Literature DB >> 33053393

IGF-I deficiency and enhanced insulin sensitivity due to a mutated growth hormone receptor gene in humans.

Jaime Guevara-Aguirre1, Carlos Torres2, Gabriela Peña2, María Palacios2, Camila Bautista2, Alexandra Guevara3, Antonio Wd Gavilanes4.   

Abstract

Human size is achieved by the coordinated expression of many genes. From conception to adulthood, a given genomic endowment is modified by highly variable environmental circumstances. During each stage of a person's life, distinct nutritional and hormonal influences continuously shape growing physical features until mature characteristics are attained. Underlying processes depend on precise provision of substrates and energy extracted by insulin action from nutrients, which allows cell proliferation, differentiation, and survival, under the concerted actions of growth hormone and insulin-like growth factor-I (IGF-I). It should be noted that growth and metabolic signaling pathways are interdependent and superimposed at multiple levels. Attainment of a fully developed human phenotype should be considered as a harmonious increment in body size rather than a simple increase in height. From this perspective we herein analyze adult features of individuals with an inactive growth hormone receptor, who consequently have severely diminished concentrations of serum insulin and endocrine IGF-I.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 33053393     DOI: 10.1016/j.mce.2020.111044

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  3 in total

1.  [Preparation of GH/tPA double transgenic mice and gene expression analysis].

Authors:  S Song; D Li; Z He; T Zhang; Y Cheng; M Zhou
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2021-11-20

2.  Safety and efficacy of ALRV5XR in men with androgenetic alopecia: A randomised, double-blinded, placebo-controlled clinical trial.

Authors:  Peter R Feldman; Klaus M Fiebig; Charles Piwko; Boris M Mints; Dennis Brown; Deborah J Cahan; Jaime Guevara-Aguirre
Journal:  EClinicalMedicine       Date:  2021-09-11

3.  Safety and efficacy of ALRV5XR in women with androgenetic alopecia or telogen effluvium: A randomised, double-blinded, placebo-controlled clinical trial.

Authors:  Peter R Feldman; Klaus M Fiebig; Charles Piwko; Boris M Mints; Dennis Brown; Deborah J Cahan; Jaime Guevara-Aguirre
Journal:  EClinicalMedicine       Date:  2021-06-24
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.